#Abu Dhabi #UAE #financial results #PureHealth #Healthcare Group

PureHealth Reports Strong Financial Performance for Q1 2025

Introduction

In a remarkable showcase of resilience and growth, PureHealth Holding PJSC, the largest healthcare group in the Middle East, announced its financial results for the first three months of 2025. With a revenue increase of 8% year-on-year, the Group achieved a revenue of USD 1.8 billion. Notably, its EBITDA peaked at USD 308.5 million, and net profit reached USD 137.6 million, reflecting a growth of 3% compared to the same quarter last year.

Detailed Financial Performance

H.E Kamal Al Maazmi, Chairman of PureHealth, emphasized the strength of the Group's integrated healthcare model, indicating that the impressive results underscore the success of their long-term strategy. He stated, "We are redefining healthcare delivery by combining operational excellence with cutting-edge innovation to raise the standard of care across the region and beyond."

Likewise, Shaista Asif, the Group's CEO, attributed the positive outcomes to increased patient volumes across their hospital networks and robust performance in their insurance sector, which has seen high renewal rates and expansion into new markets. PureHealth processed nearly 13.9 million claims during the quarter, with active membership in its insurance division climbing to 3.2 million.

The performance of PureHealth's various segments contributed to this growth. Notably, the hospital segment accounted for 59% of total revenue, increasing by 3% year-on-year to USD 1.4 billion. This segment experienced consistent patient volume growth, recording over 2.5 million interactions—a 9% increase from last year.

Inpatient visits grew by 4% to around 53,000, while outpatient volumes surged by 9% to reach 2.2 million. Impressively, the Group also expanded its hospital bed capacity by 2% to a total of 5,500 beds.

Insurance and Procurement Growth

The insurance segment reported remarkable growth with revenue reaching USD 507.4 million, a 19% increase year-on-year. This growth was supported by a 15% rise in Gross Written Premiums. New product launches and strategic partnerships, like the collaboration with AXA for international private medical insurance, helped diversify the Group's offerings, enhancing customer value.

PureHealth's procurement segment also saw an impressive revenue leap of 11% year-on-year, climbing to USD 320.6 million. This success was driven by enhanced supplier partnerships and a wider client base across the GCC. Increased demand for high-tech medical equipment contributed significantly to this growth.

Diagnostic Services and Technology Innovation

Diagnostic services reported a revenue increase of 14% year-on-year, totaling USD 71.0 million. This growth was backed by a significant rise in testing volumes and the integration of the Sheikh Shakhbout Medical City into the PureLab network.

The Technology Services segment was a standout performer, growing by an astonished 132% to USD 41.4 million. PureCS, PureHealth's tech arm, played a pivotal role in enhancing clinical and operational technologies.

Strategic Developments

Following its annual general assembly, PureHealth declared a dividend of USD 93.4 million for FY 2024, marking its first distribution since listing on the Abu Dhabi Exchange (ADX).

Moreover, PureHealth is reinforcing its leadership in healthcare delivery within the UAE through various initiatives. This includes expansions in mental health services, the introduction of new outpatient clinics, and the onboarding of over 150 new specialists. Internationally, the Group’s Circle Health in the UK is at the forefront of innovation, reflecting its continued ambition in the global healthcare market.

Future Outlook

Looking ahead, PureHealth remains steadfast in its commitment to fostering a technology-driven healthcare environment. The Group plans to enhance its global footprint through targeted acquisitions and the integration of new assets, including the Hellenic Healthcare Group in Europe. With the early repayment of USD 502.3 million in debt bolstering its financial position, PureHealth is well-equipped to seek high-growth opportunities and maintain sustainable value creation for its stakeholders.

In summary, PureHealth's comprehensive financial results for Q1 2025 signify not only a robust recovery from the pandemic's impacts but also a clear path toward sustainable growth in the evolving healthcare landscape.